REGULATORY STRATEGY & PRACTICAL EXECUTION

RegAtrium Strategy & Advisory

Scientific understanding. Clear strategy. Practical regulatory decisions.

Support for life sciences organisations navigating complex products, global submissions and digital regulatory change.

Regulatory CMC & Global Strategy

End-to-end regulatory strategy for biologics and complex products, from development and global submissions to health-authority interactions, lifecycle changes and post-approval strategy.

When this helps
You are shaping a development programme, preparing global submissions, or planning a manufacturing or post-approval change.

How we can support you

Phase-appropriate CMC strategy and evidence planning for biologics and complex products
Global submission planning that connects core scientific content with regional expectations
Preparation for health-authority questions, briefing packages and CMC interactions
Lifecycle and post-approval change strategy, including implementation considerations across markets

What we work towards

A regulatory roadmap, clear evidence priorities, and a coherent approach to submissions and lifecycle decisions.

Combination Products & Drug-Device Strategy

Regulatory strategy for drug-device combination products, connecting product development, CMC, device requirements and global regulatory pathways.

When this helps
Your programme brings together a medicine and a delivery device, or a device change introduces new regulatory questions.

How we can support you

Integrated drug-device strategy across development and registration
Alignment of CMC, device and quality requirements within the product programme
Assessment of regulatory implications when a delivery system or device component changes
Cross-functional planning to connect the evidence, documentation and global regulatory pathway

What we work towards

A shared view of product requirements, regulatory interfaces and decision points for the combined programme.

Digital Regulatory, Data & AI

Helping regulatory organisations move from document-centric to data-driven ways of working through structured regulatory data, digital submissions, automation, AI readiness and governance.

When this helps
Your team is exploring structured data, digital submissions, automation or AI and needs a practical route from ambition to readiness.

How we can support you

Review of document-centric workflows and opportunities for structured regulatory data
Data quality and governance considerations for more reliable regulatory information
Prioritisation of digital submission, automation and AI use cases
Readiness planning that connects people, process, data and regulatory oversight

What we work towards

A prioritised transformation roadmap with clear dependencies, governance considerations and next steps.

HOW WE WORK

The decision comes first.

We start with regulatory judgement and strategy, then connect the evidence to practical execution.

Define strategy

Clarify the product, markets, evidence gaps and regulatory decisions.

Agency dialogue

Frame the questions and prepare a clear scientific and regulatory position.

Deliver submission

Connect the agreed strategy to consistent, submission-ready evidence.

Manage lifecycle

Plan changes, commitments and implementation across the product lifecycle.

Discuss your next regulatory decision.

Tell us about your product, stage of development and the support you need.

Book a Call